CD26 is expressed on CML LSCs as identified by the ability of BCR::ABL1+CD34+CD38−CD26+ LSCs to repopulate immunocompromised mice with CML, compared with CD26− cells. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.